Literature DB >> 17136530

Modulation of neuronal activity in CNS pain pathways following propofol administration in rats: Fos and EEG analysis.

Ieko Kubota1, Yoshiyuki Tsuboi, Emi Shoda, Masahiro Kondo, Yuji Masuda, Junichi Kitagawa, Yoshiyuki Oi, Koichi Iwata.   

Abstract

We studied Fos expression in the central nociceptive pathways at different sedative levels in order to clarify the central mechanism of propofol's nociceptive action. Sprague-Dawley rats received propofol (PRO) or pentobarbital (PEN) and were divided into two groups with different doses of drug administration (light and deep sedative levels) based on the electroencephalogram analysis. Rats at each sedative level received heat stimulation to their face and Fos immunohistochemistry was performed at various brain sites. We also infused lidocaine into the jugular vein to test whether PRO directly activated nociceptors distributed in the vein. Fos expression in two major ascending pain pathways (lateral and medial systems) and descending modulatory system were precisely analyzed following intravenous (i.v.) administration of PRO or PEN. Many Fos protein-like immunoreactive (Fos protein-LI) cells were expressed in the trigeminal spinal nucleus caudalis (Vc), parabrachial nucleus, parafascicular nucleus, a wide area of the primary somatosensory cortex, anterior cingulate cortex, amygdala, periaqueductal gray, solitary tract nucleus, and lateral hypothalamus following heating of the face during PRO or PEN infusion. The number of Fos protein-LI cells was significantly greater in many Central nervous system regions during PRO infusion compared with PEN. Fos expression was significantly greater in the Vc and Periaqueductal gray following greater amount of PRO infusions compared, whereas they were significantly smaller in the Vc in the rats with PEN infusion. The Fos expression was significantly depressed following i.v. infusion of lidocaine before PRO administration. The present findings suggest that PRO is involved in the enhancement of Vc activity through direct activation of the primary afferent fibers innervating veins, resulting in pain induction during infusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136530     DOI: 10.1007/s00221-006-0779-x

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   2.064


  43 in total

1.  Blockade of GABAA receptors in the midbrain periaqueductal gray abolishes nociceptive spinal dorsal horn neuronal activity.

Authors:  J Sandkühler; E Willmann; Q G Fu
Journal:  Eur J Pharmacol       Date:  1989-01-24       Impact factor: 4.432

2.  GABA(A) receptor-mediated effects on expression of c-Fos in rat trigeminal nucleus following high- and low-intensity afferent stimulation.

Authors:  M Takemura; T Shimada; Y Shigenaga
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Modulation of GABA(A) receptor channel gating by pentobarbital.

Authors:  J H Steinbach; G Akk
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

4.  Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain.

Authors:  Q Zhou; H Imbe; R Dubner; K Ren
Journal:  J Comp Neurol       Date:  1999-09-20       Impact factor: 3.215

5.  Effects of isoflurane on prefrontal acetylcholine release and hypothalamic Fos response in young adult and aged rats.

Authors:  A Jansson; K Olin; T Yoshitake; B Hagman; M K Herrington; J Kehr; J Permert
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

6.  Fos-like immunoreactivity in the superficial medullary dorsal horn induced by noxious and innocuous thermal stimulation of facial skin in the rat.

Authors:  A M Strassman; B P Vos; Y Mineta; S Naderi; D Borsook; R Burstein
Journal:  J Neurophysiol       Date:  1993-11       Impact factor: 2.714

7.  Expression of the c-fos gene in spinal cord and brain cells in rats subjected to stress in conditions of exposure to various types of halothane anesthesia.

Authors:  N S Novikova; T B Kazakova; V Rogers; E A Korneva
Journal:  Neurosci Behav Physiol       Date:  2004-05

8.  The actions of propofol on gamma-aminobutyric acid-A and glycine receptors in acutely dissociated spinal dorsal horn neurons of the rat.

Authors:  Xian-Ping Dong; Tian-Le Xu
Journal:  Anesth Analg       Date:  2002-10       Impact factor: 5.108

9.  Somatotopy of spinal nociceptive processing.

Authors:  E Bullitt
Journal:  J Comp Neurol       Date:  1991-10-08       Impact factor: 3.215

10.  The general anesthetic pentobarbital slows desensitization and deactivation of the glycine receptor in the rat spinal dorsal horn neurons.

Authors:  Hui Lu; Tian-Le Xu
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

View more
  4 in total

1.  Differential effects of general anesthetics on anxiety-like behavior in formalin-induced pain: involvement of ERK activation in the anterior cingulate cortex.

Authors:  Cong Luo; Yan-Ling Zhang; Wei Luo; Fiona H Zhou; Chang-Qi Li; Jun-Mei Xu; Ru-Ping Dai
Journal:  Psychopharmacology (Berl)       Date:  2015-09-24       Impact factor: 4.530

2.  Increased phosphorylation of extracellular signal-regulated kinase in trigeminal nociceptive neurons following propofol administration in rats.

Authors:  Emi Shoda; Junichi Kitagawa; Ikuko Suzuki; Ieko Nitta-Kubota; Makiko Miyamoto; Yoshiyuki Tsuboi; Masahiro Kondo; Yuji Masuda; Yoshiyuki Oi; Ke Ren; Koichi Iwata
Journal:  J Pain       Date:  2009-04-23       Impact factor: 5.820

3.  Propofol induces ERK-dependant expression of c-Fos and Egr-1 in neuronal cells.

Authors:  Srivatsan Kidambi; Joel Yarmush; Wayne Fong; Sangeetha Kamath; Joseph Schianodicola; Yaakov Nahmias
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

Review 4.  Identifying c-fos Expression as a Strategy to Investigate the Actions of General Anesthetics on the Central Nervous System.

Authors:  Donghang Zhang; Jin Liu; Tao Zhu; Cheng Zhou
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.